Hope for relapsed myeloma: Preclinical and clinical evidence for ruxolitinib's efficacy
The Medical News,
A new research perspective was published in Oncotarget's Volume 15 on February 5, 2024, entitled, "Preclinical and clinical…
A new research perspective was published in Oncotarget's Volume 15 on February 5, 2024, entitled, "Preclinical and clinical…
image: Figure 1: Ruxolitinib exerts its anti-myeloma effects through several mechanisms.
"[...] the results of the studies presented in this review will hopefully provide the impetus for conducting additional…